Search Results

You are looking at 1 - 10 of 106 items for :

  • "treatment" x
  • Biology and Life Sciences x
  • User-accessible content x
Clear All
European Journal of Microbiology and Immunology
Authors: U. Erben, N. N. Pawlowski, M. M. Heimesaat, C. Loddenkemper, K. Doerfel, S. Spieckermann, B. Siegmund, and A. A. Kühl

RG , Papp K , Bissonnette R , Toth D , Matheson R , Hultquist M , White B : Safety profile of intravenous and subcutaneous siplizumab, an anti-CD2 monoclonal antibody, for the treatment of plaque psoriasis: results of two

Open access

still a lack of sufficient antimicrobial treatment options [ 13 ]. Therefore, the pharmacological research focus has shifted to alternative antibiotic-independent approaches in order to avoid the ongoing trigger for acquisition of resistance in bacterial

Open access

. Sterling , T : HIV infection-related tuberculosis: clinical manifestations and treatment . Clinical Infect Dis 50 S3 , S223 – S230 ( 2010 ) 10. Yassin

Open access

-drug resistant (MDR) bacterial strains has been highlighted, emphasising and contextualizing the role of “one health” [ 2 ]. This might be even further aggravated by the current wide use of antibiotics for the treatment of COVID-19 patients, in an attempt to

Open access

-inflammatory effects of NAP treatment were not restricted to the intestinal tract, given that extra-intestinal and even systemic collateral damages of inflammation could be alleviated [ 11 , 12 ]. This prompted us to elucidate potential immune-modulatory actions of

Open access
European Journal of Microbiology and Immunology
Authors: Souba Diandé, Gisèle Badoum, Adjima Combary, Issaka Zombra, Tandaogo Saouadogo, Léon T. Sawadogo, Bayéma Nébié, Saïdou Gnanou, Adama Zigani, Seydou Mohamed Ouédraogo, Adama Diallo, Seydou Kaboré, and Lassana Sangaré

are culture- or smear-positive after the 3rd month of treatment with first line drugs, relapsed patients, and patients receiving repeated treatment after non-adherence and treatment failure. The WHO recommends that the National Tuberculosis Program

Open access

buffered saline PI propidium iodide PTLDS post-treatment Lyme disease syndrome

Open access

. Santos JB , Almeida OL , Silva LM , Barreto ER : Efficacy of topical combination of benzoyl peroxide 5% and clindamycin 1% for the treatment of progressive macular hypomela nosis: a randomized, doubleblind, placebo

Open access

, Bross PF , Farrell AT , Pazdur R : Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy . The Oncologist 8 , 508 – 513 ( 2003 ) 2

Open access

, Itala-Remes M , Silvennoinen R , Koistinen P , Finnish Leukemia Group: Bloodstream infections during chemotherapy-induced neutropenia in adult patients with acute myeloid leukemia: treatment cycle matters . Eur J Clin Microbiol Infect Dis 29 , 1211

Open access